Publicaciones en las que colabora con Luis Gandía Juan (9)

2020

  1. Melatonin reduces NLRP3 inflammasome activation by increasing α7 nAChR-mediated autophagic flux

    Antioxidants, Vol. 9, Núm. 12, pp. 1-18

2018

  1. Sistema nervioso autónomo: fármacos antagonistas muscarínicos

    Velázquez. Farmacología básica y clínica (Editorial Médica Panamericana), pp. 125-136

2011

  1. Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3- carbonitriles

    Bioorganic and Medicinal Chemistry, Vol. 19, Núm. 1, pp. 122-133

2010

  1. Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles

    Bioorganic and Medicinal Chemistry, Vol. 18, Núm. 16, pp. 5861-5872

1996

  1. Blocking effects of otilonium on Ca2+ channels and secretion in rat chromaffin cells

    European Journal of Pharmacology, Vol. 298, Núm. 2, pp. 199-205

  2. Otilonium: A potent blocker of neuronal nicotinic ACh receptors in bovine chromaffin cells

    British Journal of Pharmacology, Vol. 117, Núm. 3, pp. 463-470

  3. The mechanism of calcium channel facilitation in bovine chromaffin cells

    Journal of Physiology, Vol. 494, Núm. 3, pp. 687-695

1994

  1. Interactions between Ca2+, PCA50941 and Bay K 8644 in bovine chromaffin cells

    European Journal of Pharmacology: Molecular Pharmacology, Vol. 268, Núm. 3, pp. 293-303

  2. Permeation by zinc of bovine chromaffin cell calcium channels: relevance to secretion

    Pflügers Archiv European Journal of Physiology, Vol. 429, Núm. 2, pp. 231-239